Abstract:Objective This clinical study was designed to evaluate the efficacy and safety of this therapy in the treatment of respiratory and urinary infections caused by ceftriaxone-resistant bacteria in comparison with the effect of cefoperazone/sulbactam on cefoperazone-resistant bacteria. Methods A total of 285 patients aged from 18 to 65 years old, with a respiratory or urinary tract bacterial infection, were enrolled into this multicentre, open-label, controlled clinical study, and bacteria that were either ceftriaxone-resistant or cefoperazone-resistant were isolated from the patients, whose condition had not improved after three days of treatment with ceftriaxone or cefoperazone. To be selected for the study, bacterial cultures obtained from the patients had to be positive before enrolment, and all of the isolates were required to be β-lactamase-positive. Of these patients, 253 completed the trial, and 263 were enrolled into the intention-to-treat (ITT) analysis. All of the 285 patients were included in the safety analysis. Results The cure and effective rates were 39.55% and 85.07% in the ceftriaxone/sulbactam group and 36.43% and 79.84% in the cefoperazone/sulbactam group; the bacterial eradication rates were 83.58% and 83.72%; and the adverse-event rates were 7.48% and 7.80%, respectively. There were no significant differences between the two groups (p > 0.05). Conclusion Ceftriaxone/sulbactam is as effective and well-tolerated as cefoperazone/sulbactam for the treatment of intermediate and severe bacterial infections caused by resistant strains.

Clinical Randomized Controlled Trial of Amoxycillin-sulbactam Injection in the Treatment of Bacterial Infection

Bacteriological Efficacy of Amoxicillin/sulbactam on Acute Bacterial Infections

A randomized controlled open study of ampicillin/sulbactum in the treatment of 172 cases with bacterial infections

Clinical evaluation of sulbactam/ampicillin

A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections

Multicenter Randomized Controlled Clinical Trial on Teicoplanin Versus Vancomycin

A Multicenter,randomized Controlled Clinical Trial of Imported Amoxicillin-Sulbactam in the Treatment of Community-Acquired Pneumonia

Multicenter Clinical Study on Piperacillin/Sulbactam for Treatment of Respiratory and Urinary Tract Infection

The Study on Antibacterial Activity of Amoxicillin Sulbactam Compared with Other Four Antimicrobial Agents in Vitro

A multicenter randomized control clinical trial of cefepime hydrochloride injection in the treatment of acute bacterial infections

A randomized, controlled, single blinded clinical study on domestic versus imported ceftizoxime sodium for injection in the treatment of acute bacterial infections

A Randomized Controlled Study of Cefoperazone-Tazobactam Versus Cefoperazone-Sulbactam in the Treatment of Bacterial Infections

Clinical Randomized Controlled Trials of Gatifloxacin Injection in Treatment of Bacterial Infections of Respiratory Tract

Clinical Comparative Study of Injectable Azithromycin and Cefuroxime in the Treatment of Lower Respiratory Tract Infection

Efficacy of Cefoperazone/sulbactam 2∶1 Vs Cefoperazone/sulb Actam 1∶1 in Treatment of Lower Respiratory Tract Infections

A clinical randomized controlled trial of pazufloxacin injection in treatment of bacterial infection in 111 patients

Multicenter Clinical Evaluation of Domestic Azithromycin Injection in the Treatment of Bacterial Infections

A randomized multicenter clinical study of injectable levofloxacin in the treatment of acute bacterial infections

A Multicenter Randomized Double Blind Parallel Control Clinical Trial for Amoxicillin and Clavulanate Potassium Chewable Tablet in the Treatment of Acute Bacterial Infections

Clinical Trial on Augmentin Against Acute Exacerbation of Chronic Bronchitis (AECB) in Adults

A Multicenter Randomized Controlled Clinical Trials of Ambroxol Hydrochloride Injection in Adjuvant Treatment of Respiratory Diseases